ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0502

Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Non-inflammatory Aortic Aneurysms

Benjamin Hur1, Matthew Koster1, Jin Sung Jang1, Kenneth Warrington2 and Jaeyun Sung1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, Minnesota

Meeting: ACR Convergence 2021

Keywords: Bioinformatics, Biomarkers, Gene Expression, giant cell arteritis, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders (0502–0507)

Session Type: Abstract Session

Session Time: 3:30PM-3:45PM

Background/Purpose: Non-infectious aortitis may be a manifestation of systemic large vessel vasculitis such as giant cell arteritis (GCA) or may be a form of single organ vasculitis termed ‘clinically isolated aortitis’ (CIA). Aortitis is generally diagnosed after aortic aneurysm surgery and histopathologic examination of resected aortic tissue. At current, there is no specific biomarker that assists physicians in their diagnostic and treatment decisions for aortitis. Moreover, a genome-wide expression analysis to detect differences in transcriptomic signatures between inflammatory and non-inflammatory aortic aneurysms has not been conducted to date. To this end, we used global transcriptome profiling (RNA-seq) to provide novel insights into the biomolecular processes underlying inflammatory aortic aneurysms. We also compared the transcriptomic signature of aortic tissue from patients with CIA and GCA.

Methods: RNA-seq (HiSeq 4000) was performed on formalin-fixed paraffin-embedded (FFPE) resected aortic tissue from 25 aortitis and 25 non-inflammatory aneurysm control patients undergoing surgical aortic repair (Table 1, Fig. 1). Differentially expressed genes (DEGs) between the two groups were identified while controlling for the potentially confounding effects (i.e., use of Statin, use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers, and history of other rheumatic diseases). Protein-protein interactions from STRING and drug-gene pharmacological interaction information from DBIdb were used to construct DEG interactome and pharmacogenomic networks, respectively. In addition, DAVID was used to identify enriched biomolecular functions (Gene Ontology) for the gene sets from the DEGs, the DEG interactome network, and the pharmacogenomic network.

Results: We identified 159 and 93 genes to be significantly up-regulated and down-regulated, respectively, in aortitis (adj-P < 0.01, |log2(FC)| > 2) compared to non-inflammatory aortic tissue (Fig. 2). Up-regulated genes were enriched with functions related to immune response and inflammation, defense against bacteria, and interferon response pathways; while the down-regulated genes were enriched with plasma membrane and neuronal processes. Of note, the gene expression profiles of aortic tissue from patients with aortitis related to GCA (n=8) was no different than those of aortic tissue from patients with CIA (n=17). In aortitis, 30 out of 36 genes from the hub of the DEG interactome network were enriched with immune-related functions. Finally, our pharmacogenomic network analysis identified 16 genes that could be targeted with FDA-approved drugs.

Conclusion: Global transcriptome profiling on FFPE aortic specimens from patients with aortitis identified upregulated genes related to immune response and inflammation. Interestingly, we demonstrate for the first time that the transcriptomic signature of CIA is similar to that of GCA, suggesting that CIA may be a limited presentation of GCA. This study also facilitates the characterization of dysregulated molecular pathways in aortitis, and could provide a promising direction for biomarker discovery and treatment.

FINAL_Table1.jpeg”


Disclosures: B. Hur, None; M. Koster, None; J. Jang, None; K. Warrington, Eli Lilly, 5, Kiniksa, 5; J. Sung, None.

To cite this abstract in AMA style:

Hur B, Koster M, Jang J, Warrington K, Sung J. Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Non-inflammatory Aortic Aneurysms [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/global-transcriptomic-profiling-identifies-differential-gene-expression-signatures-between-inflammatory-and-non-inflammatory-aortic-aneurysms/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/global-transcriptomic-profiling-identifies-differential-gene-expression-signatures-between-inflammatory-and-non-inflammatory-aortic-aneurysms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology